Exhibit 99.2
CRANE CO.
Income Statement Data
(in thousands, except per share data)
| | | | | | | | |
| | Three Months Ended | |
| | March 31, | |
| | 2007 | | | 2006 | |
Net Sales: | | | | | | | | |
Aerospace & Electronics | | $ | 148,392 | | | $ | 139,540 | |
Engineered Materials | | | 87,748 | | | | 85,949 | |
Merchandising Systems | | | 97,364 | | | | 52,556 | |
Fluid Handling | | | 263,124 | | | | 242,179 | |
Controls | | | 31,762 | | | | 29,329 | |
Intersegment Elimination | | | (173 | ) | | | (170 | ) |
| | | | | | | | |
Total Net Sales | | $ | 628,217 | | | $ | 549,383 | |
| | | | | | | | |
Operating Profit: | | | | | | | | |
Aerospace & Electronics | | $ | 21,026 | | | $ | 22,406 | |
Engineered Materials | | | 16,038 | | | | 15,740 | |
Merchandising Systems | | | 9,631 | | | | 3,752 | |
Fluid Handling | | | 31,141 | | | | 25,478 | |
Controls | | | 2,346 | | | | 1,540 | |
Corporate | | | (11,783 | ) | | | (11,701 | ) |
| | | | | | | | |
Total Operating Profit | | | 68,399 | | | | 57,215 | |
Interest Income | | | 1,313 | | | | 708 | |
Interest Expense | | | (6,868 | ) | | | (5,527 | ) |
Miscellaneous- Net | | | 1,813 | | | | 1,261 | |
| | | | | | | | |
Income Before Income Taxes | | | 64,657 | | | | 53,657 | |
Provision for Income Taxes | | | 21,012 | | | | 16,258 | |
| | | | | | | | |
Net Income | | $ | 43,645 | | | $ | 37,399 | |
| | | | | | | | |
Share Data: | | | | | | | | |
Net Income per Diluted Share | | $ | 0.71 | | | $ | 0.61 | |
| | | | | | | | |
Average Diluted Shares Outstanding | | | 61,207 | | | | 61,801 | |
Average Basic Shares Outstanding | | | 60,209 | | | | 60,718 | |
Supplemental Data: | | | | | | | | |
Cost of Sales | | $ | 423,683 | | | $ | 371,501 | |
Selling, General & Administrative | | | 136,135 | | | | 120,667 | |
Depreciation and Amortization * | | | 15,576 | | | | 15,265 | |
Stock Compensation Expense | | | 4,304 | | | | 4,082 | |
* | Amount included within cost of sales and selling, general & administrative costs. |
CRANE CO.
Condensed Balance Sheets
(in thousands)
| | | | | | |
| | March 31, | | December 31, |
| | 2007 | | 2006 |
ASSETS | | | | | | |
Current Assets | | | | | | |
Cash and Cash Equivalents | | $ | 133,921 | | $ | 138,607 |
Accounts Receivable | | | 358,102 | | | 330,146 |
Current Insurance Receivable - Asbestos | | | 21,000 | | | 52,500 |
Inventories | | | 327,623 | | | 313,259 |
Other Current Assets | | | 63,547 | | | 45,897 |
| | | | | | |
Total Current Assets | | | 904,193 | | | 880,409 |
Property, Plant and Equipment | | | 276,683 | | | 289,555 |
Long-Term Insurance Receivable - Asbestos | | | 164,030 | | | 170,400 |
Other Assets | | | 388,805 | | | 385,384 |
Goodwill | | | 709,246 | | | 704,736 |
| | | | | | |
Total Assets | | $ | 2,442,957 | | $ | 2,430,484 |
| | | | | | |
LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | |
Current Liabilities | | | | | | |
Notes Payable and Current Maturities of Long-Term Debt | | $ | 11,310 | | $ | 9,505 |
Accounts Payable | | | 172,479 | | | 161,270 |
Current Asbestos Liability | | | 70,000 | | | 70,000 |
Accrued Liabilities | | | 194,551 | | | 196,723 |
Income Taxes | | | 32,436 | | | 24,428 |
| | | | | | |
Total Current Liabilities | | | 480,776 | | | 461,926 |
Long-Term Debt | | | 392,115 | | | 391,760 |
Deferred Tax Liability | | | 91,822 | | | 89,595 |
Long-Term Asbestos Liability | | | 442,877 | | | 459,567 |
Other Liabilities | | | 112,789 | | | 109,033 |
Shareholders’ Equity | | | 922,578 | | | 918,603 |
| | | | | | |
Total Liabilities and Shareholders’ Equity | | $ | 2,442,957 | | $ | 2,430,484 |
| | | | | | |
CRANE CO.
Condensed Statements of Cash Flows
(in thousands)
| | | | | | | | |
| | Three Months Ended March 31, | |
| | 2007 | | | 2006 | |
Operating Activities: | | | | | | | | |
Net income | | $ | 43,645 | | | $ | 37,399 | |
Income from joint venture | | | (1,017 | ) | | | (1,761 | ) |
Depreciation and amortization | | | 15,576 | | | | 15,265 | |
Stock-based compensation expense | | | 4,304 | | | | 4,082 | |
Cash used for operating working capital | | | (25,648 | ) | | | (32,899 | ) |
Other | | | (21,151 | ) | | | 4,196 | |
| | | | | | | | |
Subtotal | | | 15,709 | | | | 26,282 | |
Asbestos related payments, net of insurance recoveries | | | 21,180 | | | | (9,300 | ) |
| | | | | | | | |
Total provided by operating activities | | | 36,889 | | | | 16,982 | |
| | | | | | | | |
Investing Activities: | | | | | | | | |
Capital expenditures | | | (6,963 | ) | | | (8,390 | ) |
Proceeds from disposition of capital assets | | | 11,032 | | | | 1,236 | |
Payment for acquisition, net of cash acquired | | | (5 | ) | | | (85,338 | ) |
| | | | | | | | |
Total provided from (used) for investing activities | | | 4,064 | | | | (92,492 | ) |
| | | | | | | | |
Financing Activities: | | | | | | | | |
Dividends paid | | | (9,050 | ) | | | (7,623 | ) |
Reacquisition of shares on open market | | | (40,001 | ) | | | (12,041 | ) |
Stock options exercised - net of shares reacquired | | | (387 | ) | | | 8,396 | |
Excess tax benefit from stock-based compensation | | | 690 | | | | 1,716 | |
Repayment of debt, net | | | 1,733 | | | | (202 | ) |
| | | | | | | | |
Total used for financing activities | | | (47,015 | ) | | | (9,754 | ) |
| | | | | | | | |
Effect of exchange rate on cash and cash equivalents | | | 1,376 | | | | 1,373 | |
| | | | | | | | |
Decrease in cash and cash equivalents | | | (4,686 | ) | | | (83,891 | ) |
Cash and cash equivalents at beginning of period | | | 138,607 | | | | 180,392 | |
| | | | | | | | |
Cash and cash equivalents at end of period | | $ | 133,921 | | | $ | 96,501 | |
| | | | | | | | |
CRANE CO.
Order Backlog
(in thousands)
| | | | | | | | | |
| | March 31, 2007 | | December 31, 2006 | | March 31, 2006 |
Aerospace & Electronics | | $ | 405,792 | | $ | 396,799 | | $ | 363,443 |
Engineered Materials | | | 17,437 | | | 13,198 | | | 16,972 |
Merchandising Systems | | | 33,231 | | | 33,170 | | | 14,838 |
Fluid Handling | | | 237,144 | | | 210,532 | | | 202,739 |
Controls | | | 33,224 | | | 22,982 | | | 23,578 |
| | | | | | | | | |
Total Backlog | | $ | 726,828 | | $ | 676,681 | | $ | 621,570 |
| | | | | | | | | |
CRANE CO.
Non-GAAP Financial Measures
(in thousands)
| | | | | | | | |
| | March 31, 2007 | | | December 31, 2006 | |
BALANCE SHEET ITEMS | | | | | | | | |
Notes Payable and Current Maturities of Long-Term Debt | | $ | 11,310 | | | $ | 9,505 | |
Long-Term Debt | | | 392,115 | | | | 391,760 | |
| | | | | | | | |
Total Debt | | | 403,425 | | | | 401,265 | |
Less Cash and Cash Equivalents | | | (133,921 | ) | | | (138,607 | ) |
| | | | | | | | |
Net Debt | | | 269,504 | | | | 262,658 | |
Shareholders’ Equity | | | 922,578 | | | | 918,603 | |
| | | | | | | | |
Total Capitalization | | $ | 1,192,082 | | | $ | 1,181,261 | |
| | | | | | | | |
Percentage of Net Debt to Total Capitalization | | | 22.6 | % | | | 22.2 | % |
| | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | | | Year Ended December 31, | |
| | 2007 | | | 2006 | | | 2007 | | | 2006 | |
| | | | | | | | (Estimated) | | | | |
CASH FLOW ITEMS | | | | | | | | | | | | | | | | |
Cash Provided from Operating Activities before Asbestos - Related Payments | | $ | 15,709 | | | $ | 26,282 | | | $ | 240,000 - 255,000 | | | $ | 222,258 | |
Asbestos Related Payments, Net of Insurance Recoveries | | | (10,320 | ) | | | (9,300 | ) | | | (51,500 | ) | | | (40,563 | ) |
Equitas Receipts | | | 31,500 | | | | — | | | | 31,500 | | | | — | |
| | | | | | | | | | | | | | | | |
Cash Provided from Operating Activities | | | 36,889 | | | | 16,982 | | | $ | 220,000 - 235,000 | | | | 181,695 | |
Less: Capital Expenditures | | | (6,963 | ) | | | (8,390 | ) | | | (45,000 | ) | | | (27,171 | ) |
| | | | | | | | | | | | | | | | |
Free Cash Flow | | $ | 29,926 | | | $ | 8,592 | | | $ | 175,000 - 190,000 | | | $ | 154,524 | |
| | | | | | | | | | | | | | | | |
Certain non-GAAP measures have been provided to facilitate comparison with the prior year.
Free cash flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, other measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.